Celgene (NASDAQ: CELG) traded lower mid-day on reports the USPTO announced Kyle Bass's IPR was accepted for review. In the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE